Elisabeth de Vries

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Anatomy

Cultured Tumor Cells

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Fiebrich Helle-Brit; Brouwers Adrienne H; Kerstens Michiel N; Pijl Milan E J; Kema Ido P; de Jong Johan R; Jager Pieter L; Elsinga Philip H; Dierckx Rudi A J O; van der Wal Jacqueline E; Sluiter Wim J; de Vries Elisabeth G E; Links Thera P
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Maduro John H; Noordhuis Maartje G; ten Hoor Klaske A; Pras Elisabeth; Arts Henriette J G; Eijsink Jasper J H; Hollema Harry; Mom Constantijne H; de Jong Steven; de Vries Elisabeth G E; de Bock Geertruida H; van der Zee Ate G J
The prognostic value of TRAIL and its death receptors in cervical cancer.
Mom Constantijne H; Verweij Jaap; Oldenhuis Corina N A M; Gietema Jourik A; Fox Norma Lynn; Miceli Renée; Eskens Ferry A L M; Loos Walter J; de Vries Elisabeth G E; Sleijfer Stefan
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Elisabeth de Vries (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Fiebrich Helle-Brit; Brouwers Adrienne H; Kerstens Michiel N; Pijl Milan E J; Kema Ido P; de Jong Johan R; Jager Pieter L; Elsinga Philip H; Dierckx Rudi A J O; van der Wal Jacqueline E; Sluiter Wim J; de Vries Elisabeth G E; Links Thera P
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
The Journal of clinical endocrinology and metabolism 2009;94(10):3922-30.
2009: Maduro John H; Noordhuis Maartje G; ten Hoor Klaske A; Pras Elisabeth; Arts Henriette J G; Eijsink Jasper J H; Hollema Harry; Mom Constantijne H; de Jong Steven; de Vries Elisabeth G E; de Bock Geertruida H; van der Zee Ate G J
The prognostic value of TRAIL and its death receptors in cervical cancer.
International journal of radiation oncology, biology, physics 2009;75(1):203-11.
2009: Mom Constantijne H; Verweij Jaap; Oldenhuis Corina N A M; Gietema Jourik A; Fox Norma Lynn; Miceli Renée; Eskens Ferry A L M; Loos Walter J; de Vries Elisabeth G E; Sleijfer Stefan
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(17):5584-90.
2009: Fiebrich Helle-Brit; Brouwers Adrienne H; Koopmans Klaas Pieter; de Vries Elisabeth G E
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
European journal of cancer (Oxford, England : 1990) 2009;45(13):2312-5.
2009: Koopmans Klaas P; Neels Oliver N; Kema Ido P; Elsinga Philip H; Links Thera P; de Vries Elisabeth G E; Jager Pieter L
Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results.
Critical reviews in oncology/hematology 2009;71(3):199-213.
2009: de Jong Wilhelmina H A; Eisenhofer Graeme; Post Wendy J; Muskiet Frits A J; de Vries Elisabeth G E; Kema Ido P
Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
The Journal of clinical endocrinology and metabolism 2009;94(8):2841-9.
2009: de Jong Wilhelmina H A; de Vries Elisabeth G E; Kema Ido P
Serotonin rising.
The New England journal of medicine 2009;360(24):2580-1; author reply 2581-2.
2009: Dijkers Eli C F; Kosterink Jos G W; Rademaker Anna P; Perk Lars R; van Dongen Guus A M S; Bart Joost; de Jong Johan R; de Vries Elisabeth G E; Lub-de Hooge Marjolijn N
Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(6):974-81.
2009: de Jonge-Peeters Susan D P W M; van der Weide Karen; Kuipers Folkert; Sluiter Wim J; de Vries Elisabeth G E; Vellenga Edo
Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells.
Annals of hematology 2009;88(6):573-80.
2009: Buijs Ciska; Mom Constantijne H; Willemse Pax H B; Marike Boezen H; Maurer J Marina; Wymenga A N Machteld; de Jong Robert S; Nieboer Peter; de Vries Elisabeth G E; Mourits Marian J E
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
Breast cancer research and treatment 2009;115(3):573-80.
2009: van der Weide Karen; de Jonge-Peeters Susan D P W M; Kuipers Folkert; de Vries Elisabeth G E; Vellenga Edo
Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3076-83.
2009: Duiker Evelien W; de Vries Elisabeth G E; Mahalingam Devalingam; Meersma Gert Jan; Boersma-van Ek Wytske; Hollema Harry; Lub-de Hooge Marjolijn N; van Dam Go M; Cool Robbert H; Quax Wim J; Samali Afshin; van der Zee Ate G J; de Jong Steven
Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2048-57.
2009: de Jong Wilhelmina H A; Smit Reinier; Bakker Stephan J L; de Vries Elisabeth G E; Kema Ido P
Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(7):603-9.
2009: Crijns Anne P G; Fehrmann Rudolf S N; de Jong Steven; Gerbens Frans; Meersma Gert Jan; Klip Harry G; Hollema Harry; Hofstra Robert M W; te Meerman Gerard J; de Vries Elisabeth G E; van der Zee Ate G J
Survival-related profile, pathways, and transcription factors in ovarian cancer.
PLoS medicine 2009;6(2):e24.
2009: van der Zee Ate G J; de Vries Elisabeth G E; Schaapveld Michael; Willemse Pax H B
[The limitations of observational research]
Nederlands tijdschrift voor geneeskunde 2009;153(3):102; author reply 102.
2009: van der Zee Ate G J; Engelen Mirjam J A; Schaapveld Michael; Karim-Kos Henrike E; de Vries Elisabeth G E; Willemse Pax H B; Otter Renée
[Primary surgery by a gynecological oncologist improves the prognosis in patients with ovarian carcinoma]
Nederlands tijdschrift voor geneeskunde 2009;153(1-2):15-9.
2009: Kruizinga Roeliene C; Bestebroer Jovanka; Berghuis Paul; de Haas Carla J C; Links Thera P; de Vries Elisabeth G E; Walenkamp Annemiek M E
Role of chemokines and their receptors in cancer.
Current pharmaceutical design 2009;15(29):3396-416.
2009: van der Horst-Schrivers Anouk N A; van Ieperen Ellen; Wymenga A N Machteld; Boezen H Marike; Weijmar-Schultz Willibrord C M; Kema Ido P; Meijer Wim G; de Herder Wouter W; Willemse Pax H B; Links Thera P; de Vries Elisabeth G E
Sexual function in patients with metastatic midgut carcinoid tumours.
Neuroendocrinology 2009;89(2):231-6.
2008: de Vries Elisabeth G E; de Jong Steven
Exploiting the apoptotic route for cancer treatment: a single hit will rarely result in a home run.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5151-3.
2008: Buijs Ciska; de Vries Elisabeth G E; Mourits Marian J E; Willemse Pax H B
The influence of endocrine treatments for breast cancer on health-related quality of life.
Cancer treatment reviews 2008;34(7):640-55.
2008: Fiebrich Helle-Brit; Brouwers Adrienne H; Links Thera P; de Vries Elisabeth G E
Images in cardiovascular medicine: myocardial metastases of carcinoid visualized by 18F-dihydroxy-phenyl-alanine positron emission tomography.
Circulation 2008;118(15):1602-4.
2008: de Haas Esther C; di Pietro Alessandra; Simpson Kathryn L; Meijer Coby; Suurmeijer Albert J H; Lancashire Lee J; Cummings J; de Jong Steven; de Vries Elisabeth G E; Dive Caroline; Gietema Jourik A
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
Neoplasia (New York, N.Y.) 2008;10(10):1041-8.
2008: Maduro John H; de Vries Elisabeth G E; Meersma Gert-Jan; Hougardy Brigitte M T; van der Zee Ate G J; de Jong Steven
Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
International journal of radiation oncology, biology, physics 2008;72(2):543-52.
2008: Tanke Marit A C; Kema Ido P; Dijck-Brouwer Janneke; Doornbos Bennard; De Vries Elisabeth G E; Korf Jakob
Low plasma tryptophan in carcinoid patients is associated with increased urinary cortisol excretion.
Psychoneuroendocrinology 2008;33(9):1297-301.
2008: Neels Oliver C; Koopmans Klaas P; Jager Pieter L; Vercauteren Laya; van Waarde Aren; Doorduin Janine; Timmer-Bosscha Hetty; Brouwers Adrienne H; de Vries Elisabeth G E; Dierckx Rudi A J O; Kema Ido P; Elsinga Philip H
Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells.
Cancer research 2008;68(17):7183-90.
2008: Hougardy Brigitte M T; Reesink-Peters Nathalie; van den Heuvel Fiona A J; ten Hoor Klaske A; Hollema Harry; de Vries Elisabeth G E; de Jong Steven; van der Zee Ate G J
A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explants.
International journal of cancer. Journal international du cancer 2008;123(6):1457-65.
2008: Schaapveld Michael; Visser Otto; Louwman W J; Willemse Pax H B; de Vries Elisabeth G E; van der Graaf Winette T A; Otter Renée; Coebergh Jan Willem W; van Leeuwen Flora E
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
Breast cancer research and treatment 2008;110(1):189-97.
2008: de Jong Wilhelmina H A; Graham Kendon S; de Vries Elisabeth G E; Kema Ido P
Urinary 5-HIAA measurement using automated on-line solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;868(1-2):28-33.
2008: Koopmans Klaas P; de Groot Jan Willem B; Plukker John T M; de Vries Elisabeth G E; Kema Ido P; Sluiter Wim J; Jager Pieter L; Links Thera P
18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(4):524-31.
2008: Koopmans Klaas P; Neels Oliver C; Kema Ido P; Elsinga Philip H; Sluiter Wim J; Vanghillewe Koen; Brouwers Adrienne H; Jager Pieter L; de Vries Elisabeth G E
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1489-95.
2008: Schaapveld Michael; Visser Otto; Louwman Marieke J; de Vries Elisabeth G E; Willemse Pax H B; Otter Renée; van der Graaf Winette T A; Coebergh Jan-Willem W; van Leeuwen Flora E
Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1239-46.
2008: Gast Marie-Christine W; van Tinteren Harm; Bontenbal Marijke; van Hoesel René Q G C M; Nooij Marianne A; Rodenhuis Sjoerd; Span Paul N; Tjan-Heijnen Vivianne C G; de Vries Elisabeth G E; Harris Nathan; Twisk Jos W R; Schellens Jan H M; Beijnen Jos H
Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.
BMC cancer 2008;8():389.
2008: Fehrmann Rudolf S N; de Jonge Hendrik J M; Ter Elst Arja; de Vries André; Crijns Anne G P; Weidenaar Alida C; Gerbens Frans; de Jong Steven; van der Zee Ate G J; de Vries Elisabeth G E; Kamps Willem A; Hofstra Robert M W; Te Meerman Gerard J; de Bont Eveline S J M
A new perspective on transcriptional system regulation (TSR): towards TSR profiling.
PloS one 2008;3(2):e1656.
2008: Van Der Horst-Schrivers Anouk N A; Slot Madeleine H E Bruins; Willemse Pax H B; Kema Ido P; De Vries Elisabeth G E; Wymenga A N Machteld
Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours.
Acta oncologica (Stockholm, Sweden) 2008;47(1):153-5.
2007: Perik Patrick J; de Korte Maarten Alexander; van Veldhuisen Dirk J; Gietema Jourik A; Sleijfer Dirk T; de Vries Elisabeth G E
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
Expert review of anticancer therapy 2007;7(12):1763-71.
2007: Buijs Ciska; Rodenhuis Sjoerd; Seynaeve Caroline M; van Hoesel Quirinus G C M; van der Wall Elsken; Smit Wim J M; Nooij Marianne A; Voest Emile; Hupperets Pierre; TenVergert Els M; van Tinteren Harm; Willemse Pax H B; Mourits Marian J E; Aaronson Neil K; Post Wendy J; de Vries Elisabeth G E
Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5403-9.
2007: van der Horst-Schrivers Anouk N A; Post Wendy J; Kema Ido P; Links Thera P; Willemse Pax H B; Wymenga A N Machteld; de Vries Elisabeth G E
Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours.
European journal of cancer (Oxford, England : 1990) 2007;43(18):2651-7.
2007: de Jong Wilhelmina H A; Graham Kendon S; van der Molen Jan C; Links Thera P; Morris Michael R; Ross H Alec; de Vries Elisabeth G E; Kema Ido P
Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry.
Clinical chemistry 2007;53(9):1684-93.
2007: Fehrmann Rudolf S N; Li Xiang-Yi; van der Zee Ate G J; de Jong Steven; Te Meerman Gerard J; de Vries Elisabeth G E; Crijns Anne P G
Profiling studies in ovarian cancer: a review.
The oncologist 2007;12(8):960-6.
2007: Mourits Marian J E; de Vries Elisabeth G E; ten Hoor Klaske A; van der Zee Ate G J; Willemse Pax H B
Beware of amenorrhea during tamoxifen: it may be a wolf in sheep's clothing.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3787-8; author reply 3788-9.
2007: Swen Jesse J; Huizinga Tom W; Gelderblom Hans; de Vries Elisabeth G E; Assendelft Willem J J; Kirchheiner Julia; Guchelaar Henk-Jan
Translating pharmacogenomics: challenges on the road to the clinic.
PLoS medicine 2007;4(8):e209.
2007: de Jonge-Peeters Susan D P W M; Kuipers Folkert; de Vries Elisabeth G E; Vellenga Edo
ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance.
Critical reviews in oncology/hematology 2007;62(3):214-26.
2007: Perik Patrick J; de Vries Elisabeth G E; Gietema Jourik A; van der Graaf Winette T A; Smilde Tom D J; Sleijfer Dirk T; van Veldhuisen Dirk J
Serum HER2 levels are increased in patients with chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(2):173-7.
2007: van der Deen Margaretha; de Vries Elisabeth G E; Visserman Hylke; Zandbergen Wouter; Postma Dirkje S; Timens Wim; Timmer-Bosscha Hetty
Cigarette smoke extract affects functional activity of MRP1 in bronchial epithelial cells.
Journal of biochemical and molecular toxicology 2007;21(5):243-51.
2007: de Jonge Hendrik J M; Fehrmann Rudolf S N; de Bont Eveline S J M; Hofstra Robert M W; Gerbens Frans; Kamps Willem A; de Vries Elisabeth G E; van der Zee Ate G J; te Meerman Gerard J; ter Elst Arja
Evidence based selection of housekeeping genes.
PloS one 2007;2(9):e898.
2006: van der Deen Margaretha; Marks Hendrik; Willemse Brigitte W M; Postma Dirkje S; Müller Michael; Smit Egbert F; Scheffer George L; Scheper Rik J; de Vries Elisabeth G E; Timens Wim
Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients.
Virchows Archiv : an international journal of pathology 2006;449(6):682-8.
2006: Perik Patrick J; De Vries Elisabeth G E; Boomsma Frans; Messerschmidt Juergen; Van Veldhuisen Dirk J; Sleijfer Dirk T; Gietema Jourik A; Van der Graaf Winette T A
The relation between soluble apoptotic proteins and subclinical cardiotoxicity in adjuvant-treated breast cancer patients.
Anticancer research 2006;26(5B):3803-11.
2006: Koopmans Klaas P; de Vries Elisabeth G E; Kema Ido P; Elsinga Philip H; Neels Oliver C; Sluiter Wim J; van der Horst-Schrivers Anouk N A; Jager Pieter L
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
The lancet oncology 2006;7(9):728-34.
2006: Jalving Mathilde; de Jong Steven; Koornstra Jan J; Boersma-van Ek Wytske; Zwart Nynke; Wesseling Jelle; de Vries Elisabeth G E; Kleibeuker Jan H
TRAIL induces apoptosis in human colorectal adenoma cell lines and human colorectal adenomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4350-6.
2006: Perik Patrick J; Lub-De Hooge Marjolijn N; Gietema Jourik A; van der Graaf Winette T A; de Korte M Alexander; Jonkman Sharon; Kosterink Jos G W; van Veldhuisen Dirk J; Sleijfer Dirk T; Jager Pieter L; de Vries Elisabeth G E
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2276-82.
2006: Peeters Susan D P W M; van der Kolk Dorina M; de Haan Gerald; Bystrykh Leonid; Kuipers Folkert; de Vries Elisabeth G E; Vellenga Edo
Selective expression of cholesterol metabolism genes in normal CD34+CD38- cells with a heterogeneous expression pattern in AML cells.
Experimental hematology 2006;34(5):622-30.
2006: Fokkema Eelco; Timens Wim; de Vries Elisabeth G E; de Jong Steven; Fidler Vaclav; Meijer Coby; Groen Harry J M
Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancers.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):241-7.
2006: de Vries Elisabeth G E; Gietema Jourik A; de Jong Steven
Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2390-3.
2006: Schaapveld Michael; de Vries Elisabeth G E; van der Graaf Winette T A; Otter Renée; de Vries Jakob; Willemse Pax H B
The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association?
Annals of surgical oncology 2006;13(4):465-74.
2006: Hougardy Brigitte M T; Maduro John H; van der Zee Ate G J; de Groot Derk Jan A; van den Heuvel Fiona A J; de Vries Elisabeth G E; de Jong Steven
Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
International journal of cancer. Journal international du cancer 2006;118(8):1892-900.
2006: Bröker Linda E; de Vos Filip Y F L; van Groeningen Cees J; Kuenen Bart C; Gall Helen E; Woo Michael H; Voi Maurizio; Gietema Jourik A; de Vries Elisabeth G E; Giaccone Giuseppe
Phase I trial with BMS-275183, a novel oral taxane with promising antitumor activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1760-7.
2006: Engelen Mirjam J A; Kos Henrike E; Willemse Pax H B; Aalders Jan G; de Vries Elisabeth G E; Schaapveld Michael; Otter Renee; van der Zee Ate G J
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Cancer 2006;106(3):589-98.
2006: Mom Constantijne H; Buijs Ciska; Willemse Pax H B; Mourits Marian J E; de Vries Elisabeth G E
Hot flushes in breast cancer patients.
Critical reviews in oncology/hematology 2006;57(1):63-77.
2006: Crijns Anne P G; Gerbens Frans; Plantinga A Edo D; Meersma Gert Jan; de Jong Steven; Hofstra Robert M W; de Vries Elisabeth G E; van der Zee Ate G J; de Bock Geertruida H; te Meerman Gerard J
A biological question and a balanced (orthogonal) design: the ingredients to efficiently analyze two-color microarrays with Confirmatory Factor Analysis.
BMC genomics 2006;7():232.
2006: Perik Patrick J; Van der Graaf Winette T A; De Vries Elisabeth G E; Boomsma Frans; Messerschmidt Juergen; Van Veldhuisen Dirk J; Sleijfer Dirk T; Gietema Jourik A
Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors.
Acta oncologica (Stockholm, Sweden) 2006;45(2):175-83.
2005: Plasschaert Sabine L A; de Bont Eveline S J M; Boezen Marike; vander Kolk Dorina M; Daenen Simon M J G; Faber Klaas Nico; Kamps Willem A; de Vries Elisabeth G E; Vellenga Edo
Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8661-8.
2005: Nieboer Peter; Buijs Ciska; Rodenhuis Sjoerd; Seynaeve Caroline; Beex Louk V A M; van der Wall Elsken; Richel Dick J; Nooij Marianne A; Voest Emile E; Hupperets Pierre; Mulder Nanno H; van der Graaf Winette T A; TenVergert Els M; van Tinteren Harm; de Vries Elisabeth G E
Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8296-304.
2005: Russo Sascha; Kema Ido P; Haagsma Elizabeth B; Boon Jim C; Willemse Pax H B; den Boer Johan A; de Vries Elisabeth G E; Korf Jakob
Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
Psychosomatic medicine 2005;67(5):773-7.
2005: Mulder Erik J; Oosterloo-Duinkerken Alida; Anderson George M; De Vries Elisabeth G E; Minderaa Ruud B; Kema Ido P
Automated on-line solid-phase extraction coupled with HPLC for measurement of 5-hydroxyindole-3-acetic acid in urine.
Clinical chemistry 2005;51(9):1698-703.
2005: Hougardy Brigitte M T; Maduro John H; van der Zee Ate G J; Willemse Pax H B; de Jong Steven; de Vries Elisabeth G E
Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.
The lancet oncology 2005;6(8):589-98.
2005: Hoekstra Ronald; de Vos Filip Y F L; Eskens Ferry A L M; Gietema Jourik A; van der Gaast Ate; Groen Harry J M; Knight Raymond A; Carr Robert A; Humerickhouse Rod A; Verweij Jaap; de Vries Elisabeth G E
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5188-97.
2005: de Jong Mirjam M; Nolte Ilja M; Te Meerman Gerard J; van der Graaf Winette T A; Oosterom Elvira; Bruinenberg Marcel; Steege Gerrit van der; Oosterwijk Jan C; van der Hout Annemarie H; Boezen H Marike; Schaapveld Michael; Kleibeuker Jan H; de Vries Elisabeth G E
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors.
European journal of cancer (Oxford, England : 1990) 2005;41(12):1819-23.
2005: Bart Joost; Dijkers Eli C F; Wegman Theodora D; de Vries Elisabeth G E; van der Graaf Winette T A; Groen Harry J M; Vaalburg Willem; Willemsen Antoon T M; Hendrikse N Harry
New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics.
British journal of pharmacology 2005;145(8):1045-51.
2005: de Jong Mirjam M; Nolte Ilja M; Te Meerman Gerard J; van der Graaf Winette T A; Mulder Marcel J; van der Steege Gerrit; Bruinenberg Marcel; Schaapveld Michael; Niessen Renée C; Berends Maran J W; Sijmons Rolf H; Hofstra Robert M W; de Vries Elisabeth G E; Kleibeuker Jan H
Colorectal cancer and the CHEK2 1100delC mutation.
Genes, chromosomes & cancer 2005;43(4):377-82.
2005: Koornstra Jan J; Jalving Mathilde; Rijcken Fleur E M; Westra Jantine; Zwart Nynke; Hollema Harry; de Vries Elisabeth G E; Hofstra Robert W M; Plukker John T M; de Jong Steven; Kleibeuker Jan H
Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.
European journal of cancer (Oxford, England : 1990) 2005;41(8):1195-202.
2005: Hougardy Brigitte M T; van der Zee Ate G J; van den Heuvel Fiona A J; Timmer Tineke; de Vries Elisabeth G E; de Jong Steven
Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Gynecologic oncology 2005;97(2):353-64.
2005: Reesink-Peters Nathalie; van der Velden Jacobus; Ten Hoor Klaske A; Boezen H Marike; de Vries Elisabeth G E; Schilthuis Marten S; Mourits Marian J E; Nijman Hans W; Aalders Jan G; Hollema Harry; Pras Elisabeth; Duk Jitze M; van der Zee Ate G J
Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1455-62.
2005: Zoodsma Margreet; Nolte Ilja M; Te Meerman Gerard J; De Vries Elisabeth G E; Van der Zee Ate G J
HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease.
International journal of oncology 2005;26(3):769-84.
2005: Zoodsma Margreet; Nolte Ilja M; Schipper Martin; Oosterom Elvira; van der Steege Gerrit; de Vries Elisabeth G E; te Meerman Gerard J; van der Zee Ate G J
Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease.
Human genetics 2005;116(4):247-54.
2005: de Jong Mirjam M; Niens Marijke; Nolte Ilja M; te Meerman Gerard J; van der Graaf Winette T A; Mulder Marcel J; van der Steege Gerrit; Bruinenberg Marcel; Schaapveld Michael; Sijmons Rolf H; Hofstra Robert M W; de Vries Elisabeth G E; Kleibeuker Jan H
The human leukocyte antigen region and colorectal cancer risk.
Diseases of the colon and rectum 2005;48(2):303-6.
2005: Maring Jan Gerard; Schouten Leonie; Greijdanus Ben; de Vries Elisabeth G E; Uges Donald R A
A simple and sensitive fully validated HPLC-UV method for the determination of 5-fluorouracil and its metabolite 5,6-dihydrofluorouracil in plasma.
Therapeutic drug monitoring 2005;27(1):25-30.
2005: Perik Patrick J; de Vries Elisabeth G E; Gietema Jourik A; van der Graaf Winette T A; Sleijfer Dirk Th; Suurmeijer Albert J H; van Veldhuisen D J
The dilemma of the strive for apoptosis in oncology: mind the heart.
Critical reviews in oncology/hematology 2005;53(2):101-13.
2005: Arts Henriette J G; de Jong Steven; Hollema Harry; Ten Hoor Klaske A; de Vries Elisabeth G E; van der Zee Ate G J
Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors.
International journal of oncology 2005;26(2):379-84.
2005: van der Deen Margaretha; de Vries Elisabeth G E; Timens Wim; Scheper Rik J; Timmer-Bosscha Hetty; Postma Dirkje S
ATP-binding cassette (ABC) transporters in normal and pathological lung.
Respiratory research 2005;6():59.
2004: Van Geelen Caroline M M; de Vries Elisabeth G E; de Jong Steven
Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2004;7(6):345-58.
2004: Phan Thi T H; van Tol Karin M; Links Thera P; Piers D Albertus; de Vries Elisabeth G E; Dullaart Robin P F; Jager Pieter L
Diagnostic I-131 scintigraphy in patients with differentiated thyroid cancer: no additional value of higher scan dose.
Annals of nuclear medicine 2004;18(8):641-6.
2004: Schaapveld Michael; de Vries Elisabeth G E; van der Graaf Winette T A; Otter Renée; Willemse Pax H B
Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study.
Journal of cancer research and clinical oncology 2004;130(10):581-90.
2004: Plasschaert Sabine L A; Groninger Ellis; Boezen Marike; Kema Ido; de Vries Elisabeth G E; Uges Donald; Veerman Anjo J P; Kamps Willem A; Vellenga Edo; de Graaf Siebold S; de Bont Eveline S J M
Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.
Clinical pharmacology and therapeutics 2004;76(3):220-9.
2004: Lub-de Hooge Marjolijn N; Kosterink Jos G W; Perik Patrick J; Nijnuis Hugo; Tran Ly; Bart Joost; Suurmeijer Albert J H; de Jong Steven; Jager Pieter L; de Vries Elisabeth G E
Preclinical characterisation of 111In-DTPA-trastuzumab.
British journal of pharmacology 2004;143(1):99-106.
2004: Lub-de Hooge Marjolin N; de Jong Steven; Vermot-Desroches Claudine; Tulleken Jaap E; de Vries Elisabeth G E; Zijlstra Jan G
Endotoxin increases plasma soluble tumor necrosis factor-related apoptosis-inducing ligand level mediated by the p38 mitogen-activated protein kinase signaling pathway.
Shock (Augusta, Ga.) 2004;22(2):186-8.
2004: Hendrikse N Harry; Kuipers Folkert; Meijer Coby; Havinga Rick; Bijleveld Charles M A; van der Graaf Winette T A; Vaalburg Willem; de Vries Elisabeth G E
In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein.
Cancer chemotherapy and pharmacology 2004;54(2):131-8.
2004: Faneyte Ian F; Peterse Johannes L; Van Tinteren Harm; Pronk Corina; Bontenbal Marijike; Beex Louk V A M; van der Wall Elsken; Richel Dick J; Nooij Marianne A; Voest Emile E; Hupperets Pierre; Ten Vergert Elisabeth M; de Vries Elisabeth G E; Rodenhuis Sjoerd; van de Vijver Marc J
Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4457-63.
2004: Schaapveld Michael; Otter Renée; de Vries Elisabeth G E; Fidler Vaclav; Grond Joris A K; van der Graaf Winette T A; de Vogel Pieter L; Willemse Pax H B
Variability in axillary lymph node dissection for breast cancer.
Journal of surgical oncology 2004;87(1):4-12.
2004: de Jong Mirjam M; Hofstra Robert M W; Kooi Krista A; Westra Jantine L; Berends Maran J W; Wu Ying; Hollema Harry; van der Sluis Tineke; van der Graaf Winette T A; de Vries Elisabeth G E; Schaapveld Michael; Sijmons Rolf H; te Meerman Gerard J; Kleibeuker Jan H
No association between two MLH3 variants (S845G and P844L)and colorectal cancer risk.
Cancer genetics and cytogenetics 2004;152(1):70-1.
2004: Buijs C; Willemse P H B; Tinga D J; Hollema H; de Vries E G; Mourits M J E
Side effects of therapy: case 2. Tamoxifen and uterine abnormalities.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2505-7.
2004: Perik Patrick J; van den Berg Maarten P; de Vries Elisabeth G E; van Veldhuisen Dirk J
Experimental animal model for anthracycline-induced heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(4):375-6.
2004: Spierings Diana C J; de Vries Elisabeth G E; Stel Alja J; te Rietstap Nelina; Vellenga Edo; de Jong Steven
Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis.
Oncogene 2004;23(28):4862-72.
2004: Russo Sascha; Boon Jim C; Kema Ido P; Willemse Pax H B; den Boer Johan A; Korf Jakob; de Vries Elisabeth G E
Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation.
Psychosomatic medicine 2004;66(3):422-5.
2004: Plasschaert Sabine L A; Van Der Kolk Dorina M; De Bont Eveline S J M; Vellenga Edo; Kamps Willem A; De Vries Elisabeth G E
Breast cancer resistance protein (BCRP) in acute leukemia.
Leukemia & lymphoma 2004;45(4):649-54.
2004: Snijders Peter J F; Breuer Roderick H J; Sutedja Thomas G; Egging Monique; Voorhorst Feja J; Steenbergen Renske D M; van der Linden Hans C; Risse Elle K; Berkhof Johannes; de Vries Elisabeth G E; van der Zee Ate G J; Postmus Pieter E; Meijer Chris J L M; Smit Egbert F
Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ).
International journal of cancer. Journal international du cancer 2004;109(3):412-7.
2004: Plasschaert Sabine L A; Kamps Willem A; Vellenga Edo; de Vries Elisabeth G E; de Bont Eveline S J M
Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?
Cancer treatment reviews 2004;30(1):37-51.
2004: van der Horst-Schrivers Anouk N A; Wymenga A N Machteld; Links Thera P; Willemse Pax H B; Kema Ido P; de Vries Elisabeth G E
Complications of midgut carcinoid tumors and carcinoid syndrome.
Neuroendocrinology 2004;80 Suppl 1():28-32.
2003: Pras Elisabeth; Wouda Jan; Willemse Pax H B; Midden Maria E; Zwart Marjolijn; de Vries Elisabeth G E; Schultz Willibrord C M Weijmar
Pilot study of vaginal plethysmography in women treated with radiotherapy for gynecological cancer.
Gynecologic oncology 2003;91(3):540-6.
2003: Berends Maran J W; Wu Ying; Sijmons Rolf H; van der Sluis Tineke; Ek Wietske Boersmavan; Ligtenberg Marjolijn J L; Arts Neeltje J W; ten Hoor Klaske A; Kleibeuker Jan H; de Vries Elisabeth G E; Mourits Marian J E; Hollema Harry; Buys Charles H C M; Hofstra Robert M W; van der Zee Ate G J
Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4364-70.
2003: Bart Joost; Willemsen Antoon T M; Groen Harry J M; van der Graaf Winette T A; Wegman Theodora D; Vaalburg Willem; de Vries Elisabeth G E; Hendrikse N Harry
Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.
NeuroImage 2003;20(3):1775-82.
2003: Plasschaert Sabine L A; van der Kolk Dorina M; de Bont Eveline S J M; Kamps Willem A; Morisaki Kuniaki; Bates Susan E; Scheffer George L; Scheper Rik J; Vellenga Edo; de Vries Elisabeth G E
The role of breast cancer resistance protein in acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5171-7.
2003: Wisman G Bea A; Hollema Harry; Helder Marco N; Knol Ageeth J; Van der Meer Gretha T; Krans Mindert; De Jong Steven; De Vries Elisabeth G E; Van der Zee Ate G J
Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.
International journal of oncology 2003;23(5):1451-9.
2003: de Jong Mirjam M; Nolte Ilja M; de Vries Elisabeth G E; Schaapveld Michael; Kleibeuker Jan H; Oosterom Elvira; Oosterwijk Jan C; van der Hout Annemarie H; van der Steege Gerrit; Bruinenberg Marcel; Boezen H Marike; Te Meerman Gerard J; van der Graaf Winette T A
The HLA class III subregion is responsible for an increased breast cancer risk.
Human molecular genetics 2003;12(18):2311-9.
2003: Schröder Carolien P; Ruiters Marcel H J; de Jong Steven; Tiebosch Anton T M G; Wesseling Jelle; Veenstra Rense; de Vries Jaap; Hoekstra Harold J; de Leij Lou F M H; de Vries Elisabeth G E
Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
International journal of cancer. Journal international du cancer 2003;106(4):611-8.
2003: Willemse Pax H B; de Vries Elisabeth G E
Intraperitoneal chemotherapy for ovarian cancer: a question of feasibility?
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2003;6(4):165-7.
2003: Spierings Diana C J; de Vries Elisabeth G E; Timens Wim; Groen Harry J M; Boezen H Marike; de Jong Steven
Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3397-405.
2003: Dodde Wilma I W; Maring Jan Gerard; Hendriks Gert; Wachters Floris M; Groen Harry J M; de Vries Elisabeth G E; Uges Donald R A
Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC.
Therapeutic drug monitoring 2003;25(4):433-40.
2003: Russo Sascha; Kema Ido P; Fokkema M Rebecca; Boon Jim C; Willemse Pax H B; de Vries Elisabeth G E; den Boer Johannes A; Korf Jakob
Tryptophan as a link between psychopathology and somatic states.
Psychosomatic medicine 2003;65(4):665-71.
2003: Koornstra Jan J; Kleibeuker Jan H; van Geelen Caroline M M; Rijcken Fleur E M; Hollema Harry; de Vries Elisabeth G E; de Jong Steven
Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.
The Journal of pathology 2003;200(3):327-35.
2003: Rodenhuis Sjoerd; Bontenbal Marijke; Beex Louk V A M; Wagstaff John; Richel Dick J; Nooij Marianne A; Voest Emile E; Hupperets Pierre; van Tinteren Harm; Peterse Hans L; TenVergert Elisabeth M; de Vries Elisabeth G E;
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.
The New England journal of medicine 2003;349(1):7-16.
2003: Spierings Diana C J; de Vries Elisabeth G E; Vellenga Edo; de Jong Steven
The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.
The Journal of pathology 2003;200(2):137-48.
2003: Meijer Wim G; Copray Sjef C V M; Hollema Harry; Kema Ido P; Zwart Nynke; Mantingh-Otter Ietje; Links Thera P; Willemse Pax H B; de Vries Elisabeth G E
Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas.
Clinical chemistry 2003;49(4):586-93.
2003: Nieboer P; Roodenburg J L; van der Laan B F; de Vries E G; Mulder N H; van der Graaf W T
Screening for infectious foci in breast cancer patients prior to high-dose chemotherapy and stem cell transplantation.
Anticancer research 2003;23(2C):1779-83.
2003: Maring Jan Gerard; Piersma Henk; van Dalen Albert; Groen Harry J M; Uges Donald R A; De Vries Elisabeth G E
Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics.
Cancer chemotherapy and pharmacology 2003;51(2):167-73.
2003: de Vries Elisabeth G E; de Hooge Marjolein N; Gietema Jourik A; de Jong Steven
Correspondence re: C. G. Ferreira et al., Apoptosis: target of cancer therapy. Clin. Cancer Res., 8: 2024-2034, 2002.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):912; author reply 913.
2003: Meijer Wim G; van der Veer Eveline; Jager Piet L; van der Jagt Erik J; Piers Bert A; Kema Ido P; de Vries Elisabeth G E; Willemse Pax H B
Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(2):184-91.
2003: Plasschaert Sabine L A; Vellenga Edo; de Bont Eveline S J M; van der Kolk Dorina M; Veerman Anjo J P; Sluiter Wim J; Daenen Simon M G; de Vries Elisabeth G E; Kamps Willem A
High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.
Leukemia & lymphoma 2003;44(1):85-95.
2002: Fokkema Eelco; Groen Harry J M; Meijer Coby; Timens Wim; de Jong Steven; de Vries Elisabeth G E
The role of apoptosis-related genes in non-small-cell lung cancer.
Clinical lung cancer 2002;4(3):174-82.
2002: de Jong Mirjam M; Nolte Ilja M; te Meerman Gerard J; van der Graaf Winette T A; de Vries Elisabeth G E; Sijmons Rolf H; Hofstra Robert M W; Kleibeuker Jan H
Low-penetrance genes and their involvement in colorectal cancer susceptibility.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1332-52.
2002: Cool Robbert H; Veenstra Marloes K; van Klompenburg Wim; Heyne René I R; Müller Michael; de Vries Elisabeth G E; van Veen Hendrik W; Konings Wil N
S-decyl-glutathione nonspecifically stimulates the ATPase activity of the nucleotide-binding domains of the human multidrug resistance-associated protein, MRP1 (ABCC1).
European journal of biochemistry / FEBS 2002;269(14):3470-8.
2002: Bart Joost; Groen Harry J M; van der Graaf Winette T A; Hollema Harry; Hendrikse N Harry; Vaalburg Willem; Sleijfer Dirk T; de Vries Elisabeth G E
An oncological view on the blood-testis barrier.
The lancet oncology 2002;3(6):357-63.
2002: Fokkema Eelco; Groen Harry J M; Helder Marco N; de Vries Elisabeth G E; Meijer Coby
JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
Biochemical pharmacology 2002;63(11):1989-96.
2002: van Tol Karin M; Jager Pieter L; Piers D Albertus; Pruim Jan; de Vries Elisabeth G E; Dullaart Robin P F; Links Thera P
Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation.
Thyroid : official journal of the American Thyroid Association 2002;12(5):381-7.
2002: Mourits M J; Böckermann I; de Vries E G; van der Zee A G; ten Hoor K A; van der Graaf W T; Sluiter W J; Willemse P H
Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy.
British journal of cancer 2002;86(10):1546-50.
2002: van der Kolk Dorina M; Vellenga Edo; Scheffer George L; Müller Michael; Bates Susan E; Scheper Rik J; de Vries Elisabeth G E
Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.
Blood 2002;99(10):3763-70.
2002: van der Kolk Dorina M; de Vries Elisabeth G E; Müller Michael; Vellenga Edo
The role of drug efflux pumps in acute myeloid leukemia.
Leukemia & lymphoma 2002;43(4):685-701.
2002: Kehrer Diederik F S; Bos Annelies M; Verweij Jaap; Groen Harry J; Loos Walter J; Sparreboom Alex; de Jonge Maja J A; Hamilton Marta; Cameron Terri; de Vries Elisabeth G E
Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1222-31.
2002: Timmer Tineke; de Vries Elisabeth G E; de Jong Steven
Fas receptor-mediated apoptosis: a clinical application?
The Journal of pathology 2002;196(2):125-34.
2002: Pras Elisabeth; Willemse Pax H B; Canrinus Alof A; de Bruijn Henk W A; Sluiter Wim J; ten Hoor Klaske A; Aalders Jan G; Szabo Ben G; de Vries Elisabeth G E
Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.
International journal of radiation oncology, biology, physics 2002;52(1):23-32.
2002: Berends Maran J W; Wu Ying; Sijmons Rolf H; Mensink Rob G J; van der Sluis Tineke; Hordijk-Hos Jannet M; de Vries Elisabeth G E; Hollema Harry; Karrenbeld Arend; Buys Charles H C M; van der Zee Ate G J; Hofstra Robert M W; Kleibeuker Jan H
Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.
American journal of human genetics 2002;70(1):26-37.
2002: van Gorkom Britta A P; Karrenbeld Arend; van der Sluis Tineke; Zwart Nynke; van der Meer Roelof; de Vries Elisabeth G E; Kleibeuker Jan H
Calcium or resistant starch does not affect colonic epithelial cell proliferation throughout the colon in adenoma patients: a randomized controlled trial.
Nutrition and cancer 2002;43(1):31-8.
2002: Komdeur Rudy; Hoekstra Harald J; van den Berg Eva; Molenaar Willemina M; Pras Elisabeth; de Vries Elisabeth G E; van der Graaf Winette T A
Metastasis in soft tissue sarcomas: prognostic criteria and treatment perspectives.
Cancer metastasis reviews 2002;21(2):167-83.
2001: Links T P; van Tol K M; Meerman G J; de Vries E G
Differentiated thyroid carcinoma: a polygenic disease.
Thyroid : official journal of the American Thyroid Association 2001;11(12):1135-40.
2001: Groen H J; de Vries E G; Wynendaele W; van der Graaf W T; Fokkema E; Lechuga M J; Poggesi I; Dirix L Y; van Oosterom A T
PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3928-33.
2001: Bos A M; de Vries E G; Dombernovsky P; Aamdal S; Uges D R; Schrijvers D; Wanders J; Roelvink M W; Hanauske A R; Bortini S; Capriati A; Crea A E; Vermorken J B
Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumours.
Cancer chemotherapy and pharmacology 2001;48(5):361-9.
2001: Hofstra L S; Bos A M; de Vries E G; van der Zee A G; Beijnen J H; Rosing H; Mulder N H; Aalders J G; Willemse P H
A phase I and pharmacokinetic study of intraperitoneal topotecan.
British journal of cancer 2001;85(11):1627-33.
2001: Withoff S; Glazenburg K L; van Veen M L; Kraak M M; Hospers G A; Störkel S; de Vries E G; Wilschut J; Daemen T
Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
Gene therapy 2001;8(20):1515-23.
2001: van der Kolk D M; de Vries E G; Noordhoek L; van den Berg E; van der Pol M A; Müller M; Vellenga E
Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(10):1544-53.
2001: Klimp A H; Hollema H; Kempinga C; van der Zee A G; de Vries E G; Daemen T
Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
Cancer research 2001;61(19):7305-9.
2001: Kema I P; Meijer W G; Meiborg G; Ooms B; Willemse P H; de Vries E G
Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection.
Clinical chemistry 2001;47(10):1811-20.
2001: van Steijn J H; Nieboer P; Hospers G A; de Vries E G; Mulder N H
Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinoma.
Anticancer research 2001;21(5):3699-700.
2001: Verweij J; de Vries E G
Clinical cancer research 2001: new agents and therapies.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2001;4(4):217-23.
2001: van Gorkom B A; Karrenbeld A; van der Sluis T; Zwart N; de Vries E G; Kleibeuker J H
Apoptosis induction by sennoside laxatives in man; escape from a protective mechanism during chronic sennoside use?
The Journal of pathology 2001;194(4):493-9.
2001: Nieboer P; de Vries E G; Mulder N H; Sleijfer D T; Willemse P H; Hospers G A; Gietema J A; Sluiter W J; van Der Graaf W T
Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.
Bone marrow transplantation 2001;27(9):959-66.
2001: Schröder C P; Wisman G B; de Jong S; van der Graaf W T; Ruiters M H; Mulder N H; de Leij L F; van der Zee A G; de Vries E G
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.
British journal of cancer 2001;84(10):1348-53.
2001: Meinardi M T; van Veldhuisen D J; Gietema J A; Dolsma W V; Boomsma F; van den Berg M P; Volkers C; Haaksma J; de Vries E G; Sleijfer D T; van der Graaf W T
Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2746-53.
2001: Mourits M J; De Vries E G; Willemse P H; Ten Hoor K A; Hollema H; Van der Zee A G
Tamoxifen treatment and gynecologic side effects: a review.
Obstetrics and gynecology 2001;97(5 Pt 2):855-66.
2001: Berends M J; Hollema H; Wu Y; van Der Sluis T; Mensink R G; ten Hoor K A; Sijmons R H; de Vries E G; Pras E; Mourits M J; Hofstra R M; Buys C H; Kleibeuker J H; van Der Zee A G
MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
International journal of cancer. Journal international du cancer 2001;92(3):398-403.
2001: Jager P L; Groen H J; van der Leest A; van Putten J W; Pieterman R M; de Vries E G; Piers D A
L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(4):579-85.
2001: van Tol K M; de Vries E G; Dullaart R P; Links T P
Differentiated thyroid carcinoma in the elderly.
Critical reviews in oncology/hematology 2001;38(1):79-91.
2001: Jager P L; Vaalburg W; Pruim J; de Vries E G; Langen K J; Piers D A
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(3):432-45.
2001: Wisman G B; Knol A J; Helder M N; Krans M; de Vries E G; Hollema H; de Jong S; van der Zee A G
Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer.
International journal of cancer. Journal international du cancer 2001;91(5):658-64.
2001: Meijera C; van Luyn M J; Nienhuis E F; Blom N; Mulder N H; de Vries E G
Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy.
Biochemical pharmacology 2001;61(5):573-8.
2001: Klimp A H; van der Vaart E; Lansink P O; Withoff S; de Vries E G; Scherphof G L; Wilschut J; Daemen T
Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF.
Gene therapy 2001;8(4):300-7.
2001: Hendrikse N H; de Vries E G; Franssen E J; Vaalburg W; van der Graaf W T
In vivo measurement of [11C]verapamil kinetics in human tissues.
European journal of clinical pharmacology 2001;56(11):827-9.
2001: Jager P L; de Vries E G; Piers D A; Timmer-Bosscha H
Uptake mechanisms of L-3-[125I]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with L-1.
Nuclear medicine communications 2001;22(1):87-96.
2001: de Jong S; Timmer T; Heijenbrok F J; de Vries E G
Death receptor ligands, in particular TRAIL, to overcome drug resistance.
Cancer metastasis reviews 2001;20(1-2):51-6.
2000: Bart J; Groen H J; Hendrikse N H; van der Graaf W T; Vaalburg W; de Vries E G
The blood-brain barrier and oncology: new insights into function and modulation.
Cancer treatment reviews 2000;26(6):449-62.
2000: Meinardi M T; Gietema J A; van Veldhuisen D J; van der Graaf W T; de Vries E G; Sleijfer D T
Long-term chemotherapy-related cardiovascular morbidity.
Cancer treatment reviews 2000;26(6):429-47.
2000: Jager P L; Meijer W G; Kema I P; Willemse P H; Piers D A; de Vries E G
L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(11):1793-800.
2000: Wisman G B; De Jong S; Meersma G J; Helder M N; Hollema H; de Vries E G; Keith W N; van der Zee A G
Telomerase in (pre)neoplastic cervical disease.
Human pathology 2000;31(10):1304-12.
2000: Jager P L; Hoekstra H J; Leeuw J; van Der Graaf W T; de Vries E G; Piers D
Routine bone scintigraphy in primary staging of soft tissue sarcoma; Is it worthwhile?
Cancer 2000;89(8):1726-31.
2000: Meijer W G; Kema I P; Volmer M; Willemse P H; de Vries E G
Discriminating capacity of indole markers in the diagnosis of carcinoid tumors.
Clinical chemistry 2000;46(10):1588-96.
2000: van der Kolk D M; de Vries E G; van Putten W J; Verdonck L F; Ossenkoppele G J; Verhoef G E; Vellenga E
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3205-14.
2000: Klimp A H; De Vries E G; Scherphof G L; Daemen T
Chemo-immunotherapy of ovarian cancer in a murine tumour model.
Anticancer research 2000;20(4):2585-92.
2000: Schröder C P; Kroesen B J; de Leij L F; de Vries E G
Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2521-7.
2000: Jager P L; Plaat B E; de Vries E G; Molenaar W M; Vaalburg W; Piers D A; Hoekstra H J
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2252-9.
2000: Bos A M; de Graaf H; de Vries E G; Piersma H; Willemse P H
Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer.
British journal of cancer 2000;82(12):1920-4.
2000: Tio R A; Nieken J; de Vries E G; Pfeiffer C; de Jongste M J; Pieper E; Moshage H; Limburg P C; Mulder N H
Negative inotropic effects of recombinant interleukin 2 in patients without left ventricular dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2000;2(2):167-73.
2000: van Der Kolk D M; Vellenga E; van Der Veen A Y; Noordhoek L; Timmer-Bosscha H; Ossenkoppele G J; Raymakers R A; Müller M; van Den Berg E; de Vries E G
Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity.
Blood 2000;95(11):3514-9.
2000: Rodenhuis S; Huitema A D; van Dam F S; de Vries E G; Beijnen J H
High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer.
Cancer journal (Sudbury, Mass.) 2000;6 Suppl 2():S125-30.
2000: Hofstra L S; de Vries E G; Mulder N H; Willemse P H
Intraperitoneal chemotherapy in ovarian cancer.
Cancer treatment reviews 2000;26(2):133-43.
2000: Meinardi M T; Gietema J A; van der Graaf W T; van Veldhuisen D J; Runne M A; Sluiter W J; de Vries E G; Willemse P B; Mulder N H; van den Berg M P; Koops H S; Sleijfer D T
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1725-32.
2000: Beentjes J A; van Gorkom B A; Sluiter W J; de Vries E G; Kleibeuker J H; Dullaart R P
One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults.
Clinical endocrinology 2000;52(4):457-62.
2000: Meijer C; Timmer A; De Vries E G; Groten J P; Knol A; Zwart N; Dam W A; Sleijfer D T; Mulder N H
Role of metallothionein in cisplatin sensitivity of germ-cell tumours.
International journal of cancer. Journal international du cancer 2000;85(6):777-81.
2000: Fokkema E; Verweij J; van Oosterom A T; Uges D R; Spinelli R; Valota O; de Vries E G; Groen H J
A prolonged methoxymorpholino doxorubicin (PNU-152243 or MMRDX) infusion schedule in patients with solid tumours: a phase 1 and pharmacokinetic study.
British journal of cancer 2000;82(4):767-71.
2000: van Gorkom B A; Karrenbeld A; van Der Sluis T; Koudstaal J; de Vries E G; Kleibeuker J H
Influence of a highly purified senna extract on colonic epithelium.
Digestion 2000;61(2):113-20.
2000: Fokkema E; de Vries E G; Meijer S; Groen H J
Lack of nephrotoxicity of new oral platinum drug JM216 in lung cancer patients.
Cancer chemotherapy and pharmacology 2000;45(1):89-92.
1999: Katsaros D; Fracchioli S; Arts H J; de Vries E G; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee A G; Suurmeijer A J; Massobrio M
[Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]
Minerva ginecologica 1999;51(12):463-70.
1999: Rodenhuis S; de Wit R; de Mulder P H; Keizer H J; Sleijfer D T; Lalisang R I; Bakker P J; Mandjes I; Kooi M; de Vries E G
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(12):1467-73.
1999: van Enckevort P J; TenVergert E M; Schrantee S; Rutten F F; de Vries E G
Economic evaluations of systemic adjuvant breast cancer treatments: methodological issues and a critical review.
Critical reviews in oncology/hematology 1999;32(2):113-24.
1999: Arts H J; Katsaros D; de Vries E G; Massobrio M; Genta F; Danese S; Arisio R; Scheper R J; Kool M; Scheffer G L; Willemse P H; van der Zee A G; Suurmeijer A J
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2798-805.
1999: Meinardi M T; van der Graaf W T; van Veldhuisen D J; Gietema J A; de Vries E G; Sleijfer D T
Detection of anthracycline-induced cardiotoxicity.
Cancer treatment reviews 1999;25(4):237-47.
1999: Hofstra L S; Mourits M J; de Vries E G; Mulder N H; Willemse P H
Combined treatment with goserelin and tamoxifen in patients with advanced chemotherapy resistant ovarian cancer.
Anticancer research 1999;19(4C):3627-30.
1999: Nieken J; Mulder N H; Pietens J; Limburg P C; de Leij L; de Vries E G
The modulatory impact of recombinant human interleukin-6 on the immune system of cancer patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(4):363-70.
1999: Asschert J G; Vellenga E; Ruiters M H; de Vries E G
Regulation of spontaneous and TNF/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines.
International journal of cancer. Journal international du cancer 1999;82(2):244-9.
1999: Wymenga A N; van der Graaf W T; Hofstra L S; Spijkervet F K; Timens W; Timmer-Bosscha H; Sluiter W J; van Buuren A H; Mulder N H; de Vries E G
Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1363-8.
1999: Arts H J; Hollema H; Lemstra W; Willemse P H; De Vries E G; Kampinga H H; Van der Zee A G
Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis.
International journal of cancer. Journal international du cancer 1999;84(3):234-8.
1999: Bakker M; van der Graaf W T; Piers D A; Franssen E J; Groen H J; Smit E F; Kool W; Hollema H; Müller E A; De Vries E G
99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours.
Anticancer research 1999;19(3B):2349-53.
1999: Schröder C P; de Vries E G; Mulder N H; Willemse P H; Sleijfer D T; Hospers G A; van der Graaf W T
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.
The Journal of antimicrobial chemotherapy 1999;43(5):741-3.
1999: Hospers G A; Eisenhauer E A; de Vries E G
The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects.
British journal of cancer 1999;80(5-6):629-38.
1999: Hendrikse N H; de Vries E G; Eriks-Fluks L; van der Graaf W T; Hospers G A; Willemsen A T; Vaalburg W; Franssen E J
A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Cancer research 1999;59(10):2411-6.
1999: Wymenga A N; Eriksson B; Salmela P I; Jacobsen M B; Van Cutsem E J; Fiasse R H; Välimäki M J; Renstrup J; de Vries E G; Oberg K E
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1111.
1999: van Gorkom B A; de Vries E G; Karrenbeld A; Kleibeuker J H
Review article: anthranoid laxatives and their potential carcinogenic effects.
Alimentary pharmacology & therapeutics 1999;13(4):443-52.
1999: Mourits M J; de Vries E G; Willemse P H; ten Hoor K A; Hollema H; Sluiter W J; de Bruijn H W; van der Zee A G
Ovarian cysts in women receiving tamoxifen for breast cancer.
British journal of cancer 1999;79(11-12):1761-4.
1999: Asschert J G; De Vries E G; De Jong S; Withoff S; Vellenga E
Differential regulation of IL-6 promoter activity in a human ovarian-tumor cell line transfected with various p53 mutants: involvement of AP-1.
International journal of cancer. Journal international du cancer 1999;81(2):236-42.
1999: Mourits M J; Van der Zee A G; Willemse P H; Ten Hoor K A; Hollema H; De Vries E G
Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
Gynecologic oncology 1999;73(1):21-6.
1999: Tjeerdsma G; Meinardi M T; van Der Graaf W T; van Den Berg M P; Mulder N H; Crijns H J; de Vries E G; van Veldhuisen D J
Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables.
Heart (British Cardiac Society) 1999;81(4):419-23.
1999: Meersma G J; Bakker M; Groen H J; Van der Zee A G; Jensen P B; Giaccone G; De Vries E G; Smit E F
A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimens.
Anticancer research 1999;19(2A):1309-15.
1999: Hendrikse N H; Franssen E J; van der Graaf W T; Vaalburg W; de Vries E G
Visualization of multidrug resistance in vivo.
European journal of nuclear medicine 1999;26(3):283-93.
1999: Berends M J; Kleibeuker J H; de Vries E G; Mourits M J; Hollema H; Pras E; van der Zee A G
The importance of family history in young patients with endometrial cancer.
European journal of obstetrics, gynecology, and reproductive biology 1999;82(2):139-41.
1999: Renes J; de Vries E G; Nienhuis E F; Jansen P L; Müller M
ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.
British journal of pharmacology 1999;126(3):681-8.
1999: de Jong R S; Mulder N H; Uges D R; Sleijfer D T; Höppener F J; Groen H J; Willemse P H; van der Graaf W T; de Vries E G
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.
British journal of cancer 1999;79(5-6):882-7.
1999: Withoff S; van der Zee A G; de Jong S; Hollema H; Smit E F; Mulder N H; de Vries E G
DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
British journal of cancer 1999;79(5-6):748-53.
1999: Klimp A H; Regts J; Scherphof G L; de Vries E G; Daemen T
Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.
British journal of cancer 1999;79(1):89-94.
1999: van der Kolk D M; Vellenga E; Müller M; de Vries E G
Multidrug resistance protein MRP1, glutathione, and related enzymes. Their importance in acute myeloid leukemia.
Advances in experimental medicine and biology 1999;457():187-98.
1998: Hofstra L S; Kristensen G B; Willemse P H; Vindevoghel A; Meden H; Lahousen M; Oberling F; Sorbe B; Crump M; Sklenar I; Sluiter W J; Kiese B; Trope C G; de Vries E G
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3335-44.
1998: Jager P L; Franssen E J; Kool W; Szabó B G; Hoekstra H J; Groen H J; de Vries E G; van Imhoff G W; Vaalburg W; Piers D A
Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(10):1736-43.
1998: Hendrikse N H; Schinkel A H; de Vries E G; Fluks E; Van der Graaf W T; Willemsen A T; Vaalburg W; Franssen E J
Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography.
British journal of pharmacology 1998;124(7):1413-8.
1998: Wymenga A N; de Vries E G; Leijsma M K; Kema I P; Kleibeuker J H
Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome.
European journal of cancer (Oxford, England : 1990) 1998;34(8):1293-4.
1998: van der Kolk D M; de Vries E G; Koning J A; van den Berg E; Müller M; Vellenga E
Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(7):1727-36.
1998: Wisman G B; Hollema H; de Jong S; ter Schegget J; Tjong-A-Hung S P; Ruiters M H; Krans M; de Vries E G; van der Zee A G
Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2238-45.
1998: Asschert J G; Vellenga E; De Jong S; de Vries E G
Mutual interactions between p53 and growth factors in cancer.
Anticancer research 1998;18(3A):1713-25.
1998: Arts H J; Willemse P H; Tinga D J; de Vries E G; van der Zee A G
Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma.
Gynecologic oncology 1998;69(1):32-5.
1998: Van Luyn M J; Müller M; Renes J; Meijer C; Scheper R J; Nienhuis E F; Mulder N H; Jansen P L; De Vries E G
Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1.
International journal of cancer. Journal international du cancer 1998;76(1):55-62.
1998: van Waardenburg R C; Meijer C; Pinto-Sietsma S J; de Vries E G; Timens W; Mulder N M
Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
Anticancer research 1998;18(1A):91-5.
1998: de Jong K P; Brouwers M A; van Veen M L; Brinker M; de Vries E G; Daemen T; Scherphof G L; Slooff M J
Serum obtained from rats after partial hepatectomy enhances growth of cultured colon carcinoma cells.
Invasion & metastasis 1998;18(3):155-64.
1998: de Bruijn H W; Duk J M; van der Zee A G; Pras E; Willemse P H; Boonstra H; Hollema H; Mourits M J; de Vries E G; Aalders J G
The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19(6):505-16.
1998: de Jong R S; de Vries E G; Meijer S; de Jong P E; Mulder N H
Renal toxicity of the anticancer drug fostriecin.
Cancer chemotherapy and pharmacology 1998;42(2):160-4.
1998: Timmer-Bosscha H; de Vries E G; Meijer C; Oosterhuis J W; Mulder N H
Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line.
Cancer chemotherapy and pharmacology 1998;41(6):469-76.
1998: Hendrikse N H; Franssen E J; van der Graaf W T; Meijer C; Piers D A; Vaalburg W; de Vries E G
99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.
British journal of cancer 1998;77(3):353-8.
1998: Bakker M; Droz J P; Hanauske A R; Verweij J; van Oosterom A T; Groen H J; Pacciarini M A; Domenigoni L; van Weissenbruch F; Pianezzola E; de Vries E G
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.
British journal of cancer 1998;77(1):139-46.
1997: Asschert J G; Vellenga E; Hollema H; van der Zee A G; de Vries E G
Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6, (IL-6), interleukin-1 beta (IL-1 beta), interleukin-11 (IL-11) and tumour necrosis factor-alpha (TNF-alpha) in p53-characterised human ovarian carcinomas.
European journal of cancer (Oxford, England : 1990) 1997;33(13):2246-51.
1997: Kroesen B J; Nieken J; Sleijfer D T; Molema G; de Vries E G; Groen H J; Helfrich W; The T H; Mulder N H; de Leij L
Approaches to lung cancer treatment using the CD3 x EGP-2-directed bispecific monoclonal antibody BIS-1.
Cancer immunology, immunotherapy : CII 1997;45(3-4):203-6.
1997: Van Waardenburg R C; Meijer C; Burger H; Nooter K; De Vries E G; Mulder N H; De Jong S
Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell-lung-carcinoma cell line.
International journal of cancer. Journal international du cancer 1997;73(4):544-50.
1997: Bakker M; Renes J; Groenhuijzen A; Visser P; Timmer-Bosscha H; Müller M; Groen H J; Smit E F; de Vries E G
Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines.
International journal of cancer. Journal international du cancer 1997;73(3):362-6.
1997: Hofstra L S; van der Graaf W T; de Vries E G; Haaxma-Reiche H; Willemse P H
Ataxia following docetaxel infusion.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):812-3.
1997: de Jong R S; Hofstra L S; Willemse P H; de Bruijn H W; de Vries E G; Boonstra H; Mulder N H
Effect of low-dose oral etoposide on serum CA-125 in patients with advanced epithelial ovarian cancer.
Gynecologic oncology 1997;66(2):197-201.
1997: van Gorkom B A; Cats A; van der Meer R; Kuipers F; Verschueren R C; Mulder N H; de Vries E G; Kleibeuker J H
Effects of hemicolectomy on bile acid metabolism in relation to colon carcinogenesis in man.
European journal of clinical investigation 1997;27(7):589-94.
1997: de Jong R S; de Vries E G; Mulder N H
Fostriecin: a review of the preclinical data.
Anti-cancer drugs 1997;8(5):413-8.
1997: de Graaf T W; de Jong S; de Vries E G; Mulder N H
Expression of proteins correlated with the unique cisplatin-sensitivity of testicular cancer.
Anticancer research 1997;17(1A):369-75.
1997: Dolsma W V; De Vries E G; Van der Mark T W; Sleijfer D T; Willemse P H; Van Der Graaf W T; Mulder P O; Szabó B G; Mulder N H
Pulmonary function after high-dose chemotherapy with autologous bone marrow transplantation and radiotherapy in patients with advanced loco-regional breast cancer.
Anticancer research 1997;17(1B):537-40.
1997: de Jong R S; Slijfer E A; Uges D R; Mulder N H; de Vries E G
Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
British journal of cancer 1997;76(11):1480-3.
1997: Wymenga A N; van der Graaf W T; Spijkervet F L; Timens W; Timmer-Bosscha H; Sluiter W J; de Vries E G; Mulder N H
A new in vitro assay for quantitation of chemotherapy-induced mucositis.
British journal of cancer 1997;76(8):1062-6.
1997: de Graaf H; Dolsma W V; Willemse P H; van der Graaf W T; Sleijfer D T; de Vries E G; Mulder N H
Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.
British journal of cancer 1997;76(7):943-5.
1997: Meijer C; de Vries E G; Dam W A; Wilkinson M H; Hollema H; Hoekstra H J; Mulder N H
Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.
British journal of cancer 1997;76(3):290-8.
1997: Helfrich W; ten Poele R; Meersma G J; Mulder N H; de Vries E G; de Leij L; Smit E F
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood.
British journal of cancer 1997;76(1):29-35.
1997: Hettinga J V; Lemstra W; Meijer C; Dam W A; Uges D R; Konings A W; De Vries E G; Kampinga H H
Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
British journal of cancer 1997;75(12):1735-43.
1997: de Jong R S; Mulder N H; Uges D R; Kaul S; Winograd B; Sleijfer DTh; Groen H J; Willemse P H; van der Graaf W T; de Vries E G
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
British journal of cancer 1997;75(11):1660-6.
1997: Veldhuis G J; Willemse P H; Beijnen J H; Boonstra H; Piersma H; van der Graaf W T; de Vries E G
Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.
British journal of cancer 1997;75(5):703-9.
1996: Withoff S; de Vries E G; Keith W N; Nienhuis E F; van der Graaf W T; Uges D R; Mulder N H
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
British journal of cancer 1996;74(12):1869-76.
1996: van Ginkel R J; Schraffordt Koops H; de Vries E G; Molenaar W M; Uges D R; Hoekstra H J
Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1996;22(5):528-31.
1996: Sleijfer S; Willemse P H; de Vries E G; van der Graaf W T; Schraffordt Koops H; Mulder N H
Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.
British journal of cancer 1996;74(6):947-50.
1996: Hettinga J V; Lemstra W; Meijer C; Los G; de Vries E G; Konings A W; Kampinga H H
Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells.
International journal of cancer. Journal international du cancer 1996;67(6):800-7.
1996: Elsinga P H; Franssen E J; Hendrikse N H; Fluks L; Weemaes A M; van der Graaf W T; de Vries E G; Visser G M; Vaalburg W
Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1571-5.
1996: Withoff S; Keith W N; Knol A J; Coutts J C; Hoare S F; Mulder N H; de Vries E G
Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.
British journal of cancer 1996;74(4):502-7.
1996: Wymenga A N; van der Graaf W T; Wils J A; Siegenbeek van Heukelom L; van der Linden G H; Dullemond-Westland A C; Nooy M; van der Heul C; de Bruijn K M; de Vries E G
A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):505-10.
1996: Van Waardenburg R C; Prins J; Meijer C; Uges D R; De Vries E G; Mulder N H
Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
Anticancer research 1996;16(4A):1963-70.
1996: Withoff S; De Jong S; De Vries E G; Mulder N H
Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review).
Anticancer research 1996;16(4A):1867-80.
1996: Veldhuis G J; van der Leest A H; de Wolf J T; de Vries E G; Vellenga E
A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects.
Annals of hematology 1996;73(1):47-50.
1996: de Graaf H; Willemse P H; Bong S B; Piersma H; Tjabbes T; van Veelen H; Coenen J L; de Vries E G
Dose intensity of standard adjuvant CMF with granulocyte colony-stimulating factor for premenopausal patients with node-positive breast cancer.
Oncology 1996;53(4):289-94.
1996: Groen H J; Meijer C; De Vries E G; Mulder N H
Red blood cell glutathione levels in lung cancer patients treated by radiation and continuously infused carboplatin.
Anticancer research 1996;16(2):1033-7.
1996: Veldhuis G J; Willemse P H; Mulder N H; Limburg P C; De Vries E G
Potential use of recombinant human interleukin-6 in clinical oncology.
Leukemia & lymphoma 1996;20(5-6):373-9.
1996: Vellenga E; Uyl-de Groot C A; de Wit R; Keizer H J; Löwenberg B; ten Haaft M A; de Witte T J; Verhagen C A; Stoter G J; Rutten F F; Mulder N H; Smid W M; de Vries E G
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):619-27.
1996: Cats A; Dullaart R P; Kleibeuker J H; Kuipers F; Sluiter W J; Hardonk M J; de Vries E G
Increased epithelial cell proliferation in the colon of patients with acromegaly.
Cancer research 1996;56(3):523-6.
1996: Müller M; de Vries E G; Jansen P L
Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells.
Journal of hepatology 1996;24 Suppl 1():100-8.
1996: de Vries E G; Rodenhuis S; Schouten H C; Hupperets P S; Dolsma W V; Lebesque J V; Blijham G H; Bontenbal M; Mulder N H
Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer.
Breast cancer research and treatment 1996;39(3):307-13.
1995: Groen H J; van der Mark T W; van der Leest A H; de Vries E G; Mulder N H
Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin.
American journal of respiratory and critical care medicine 1995;152(6 Pt 1):2044-8.
1995: Groen H J; Sleijfer S; Meijer C; Kampinga H H; Konings A W; De Vries E G; Mulder N H
Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
British journal of cancer 1995;72(6):1406-11.
1995: de Graaf H; Mulder N H; Willemse P H; van der Graaf W T; Sleijfer D T; Zijlstra J G; Elias M; Sibinga C T; Vellenga E; de Vries E G
The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
Anticancer research 1995;15(6B):2851-6.
1995: de Vries E G; de Graaf H; Boonstra A; van der Graaf W T; Mulder N H
High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors.
Stem cells (Dayton, Ohio) 1995;13(6):597-606.
1995: Veldhuis G J; Willemse P H; Sleijfer D T; van der Graaf W T; Groen H J; Limburg P C; Mulder N H; de Vries E G
Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2585-93.
1995: Groen H J; van der Leest A H; de Vries E G; Uges D R; Szabó B G; Mulder N H
Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.
British journal of cancer 1995;72(4):992-7.
1995: de Jong R S; Mulder N H; Dijksterhuis D; de Vries E G
Review of current clinical experience with prolonged (oral) etoposide in cancer treatment.
Anticancer research 1995;15(5B):2319-30.
1995: van der Zee A G; Hollema H H; de Bruijn H W; Willemse P H; Boonstra H; Mulder N H; Aalders J G; de Vries E G
Cell biological markers of drug resistance in ovarian carcinoma.
Gynecologic oncology 1995;58(2):165-78.
1995: Nieken J; Mulder N H; Buter J; Vellenga E; Limburg P C; Piers D A; de Vries E G
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients.
Blood 1995;86(3):900-5.
1995: Mulder N H; Dolsma W V; Mulder P O; De Vries E G; Willemse P H; Sleijfer D T; Hospers G A; Van der Graaf W T
Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer.
Anticancer research 1995;15(4):1565-8.
1995: Kleibeuker J H; van der Meer R; de Vries E G
Calcium and vitamin D: possible protective agents against colorectal cancer?
European journal of cancer (Oxford, England : 1990) 1995;31A(7-8):1081-4.
1995: Gietema J A; Veldhuis G J; Guchelaar H J; Willemse P H; Uges D R; Cats A; Boonstra H; van der Graaf W T; Sleijfer D T; de Vries E G
Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.
British journal of cancer 1995;71(6):1302-7.
1995: Hettinga J V; Lemstra W; De Vries E G; Konings A W; Kampinga H H
Sensitization to cisplatin action by step-down heating in cDDP-sensitive and -resistant cells.
International journal of cancer. Journal international du cancer 1995;61(5):722-6.
1995: Sleijfer S; Van der Graaf W T; Willemse P H; De Vries E G; Schraffordt Koops H; Mulder N H
High-dose methotrexate, vincristine and cisplatin as salvage treatment for relapsed non-seminomatous germ-cell cancer.
Anticancer research 1995;15(3):1039-42.
1995: Cats A; Kleibeuker J H; van der Meer R; Kuipers F; Sluiter W J; Hardonk M J; Oremus E T; Mulder N H; de Vries E G
Randomized, double-blinded, placebo-controlled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer.
Journal of the National Cancer Institute 1995;87(8):598-603.
1995: Sark M W; Timmer-Bosscha H; Meijer C; Uges D R; Sluiter W J; Peters W H; Mulder N H; de Vries E G
Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
British journal of cancer 1995;71(4):684-90.
1995: Veldhuis G J; Willemse P H; van Gameren M M; Aalders J G; Mulder N H; Mull B; Biesma B; de Vries E G
Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):733-40.
1995: Buter J; Sinnige H A; Sleijfer D T; de Vries E G; Willemse P H; van der Graaf W T; Verschueren R C; Mulder N H
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration.
Cancer 1995;75(5):1072-6.
1995: Kleibeuker J H; Cats A; Zwart N; Mulder N H; Hardonk M J; de Vries E G
Excessively high cell proliferation in sigmoid colon after an oral purge with anthraquinone glycosides.
Journal of the National Cancer Institute 1995;87(6):452-3.
1995: van der Zee A G; de Cuyper E M; Limburg P C; de Bruijn H W; Hollema H; Bijzet J; Krans M; de Vries E G
Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts.
Cancer 1995;75(4):1004-9.
1995: van der Graaf W T; Zijlstra J G; de Vries E G; Nethersell A B; Mulder N H
In vitro and in vivo studies on the action of BW502U83, an arylmethylaminopropanediol.
Anti-cancer drugs 1995;6(1):34-9.
1995: van der Zee A G; Hollema H; Suurmeijer A J; Krans M; Sluiter W J; Willemse P H; Aalders J G; de Vries E G
Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):70-8.
1995: van der Graaf W T; Mulder N H; Meijer C; de Vries E G
The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts.
Cancer chemotherapy and pharmacology 1995;35(4):345-8.
1995: de Jong R S; Willemse P H; Boonstra H; de Vries E G; van der Graaf W T; Sleijfer D T; van der Zee A G; Mulder N H
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):709-13.
1995: Schröder C P; van der Graaf W T; Kema I P; Groenewegen A; Sleijfer D T; de Vries E G
Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.
Cancer chemotherapy and pharmacology 1995;36(6):477-82.
1994: Bleeker W A; de Vries E G; Dolsma W V; Grond J; Verschueren R C
Long-term disease-free survival after isolated peritoneal metastasis from colonic cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1994;20(6):698-700.
1994: Müller M; Meijer C; Zaman G J; Borst P; Scheper R J; Mulder N H; de Vries E G; Jansen P L
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(26):13033-7.
1994: Willemse P H; Boonstra H; de Vries E G
Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.
Seminars in oncology 1994;21(6 Suppl 16):44-50.
1994: Hettinga J V; Lemstra W; Meijer C; Mulder N H; Konings A W; de Vries E G; Kampinga H H
Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant subline.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1994;10(6):795-805.
1994: de Graaf H; Willemse P H; Sleijfer D T; de Vries E G; Van der Graaf W T; Beukema J; Mulder N H
Effective conditioning regimen for premenopausal patients with advanced breast cancer.
Anticancer research 1994;14(6B):2799-804.
1994: van der Graaf W T; de Vries E G; Timmer-Bosscha H; Meersma G J; Mesander G; Vellenga E; Mulder N H
Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
Cancer research 1994;54(20):5368-73.
1994: Mulder N H; van der Graaf W T; Willemse P H; Koops H S; de Vries E G; Sleijfer D T
Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.
British journal of cancer 1994;70(4):681-3.
1994: van Gameren M M; Willemse P H; Mulder N H; Limburg P C; Groen H J; Vellenga E; de Vries E G
Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study.
Blood 1994;84(5):1434-41.
1994: Guchelaar H J; de Vries E G; Meijer C; Esselink M T; Vellenga E; Uges D R; Mulder N H
Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro.
Pharmaceutical research 1994;11(9):1265-9.
1994: Withoff S; Smit E F; Meersma G J; van den Berg A; Timmer-Bosscha H; Kok K; Postmus P E; Mulder N H; de Vries E G; Buys C H
Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
Laboratory investigation; a journal of technical methods and pathology 1994;71(1):61-6.
1994: Buter J; Sleijfer D T; Willemse P H; van der Graaf W T; de Vries E G; Schraffordt Koops H; Mulder N H
Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanoma.
Anticancer research 1994;14(3B):1325-8.
1994: Kleibeuker J H; Cats A; van der Meer R; Lapré J A; de Vries E G
Calcium supplementation as prophylaxis against colon cancer?
Digestive diseases (Basel, Switzerland) 1994;12(2):85-97.
1994: van der Zee A G; de Jong S; Keith W N; Hollema H; Boonstra H; de Vries E G
Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.
Cancer research 1994;54(3):749-55.
1994: van der Zee A G; de Vries E G; Hollema H; Kaye S B; Brown R; Keith W N
Molecular analysis of the topoisomerase II alpha gene and its expression in human ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(1):75-81.
1994: Kema I P; de Vries E G; Slooff M J; Biesma B; Muskiet F A
Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors.
Clinical chemistry 1994;40(1):86-95.
1994: de Graaf H; Willemse P H; de Vries E G; Sleijfer D T; Mulder P O; van der Graaf W T; Smit Sibinga C T; van der Ploeg E; Dolsma W V; Mulder N H
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes.
European journal of cancer (Oxford, England : 1990) 1994;30A(2):150-3.
1994: Welberg J W; Monkelbaan J F; de Vries E G; Muskiet F A; Cats A; Oremus E T; Boersma-van Ek W; van Rijsbergen H; van der Meer R; Mulder N H
Effects of supplemental dietary calcium on quantitative and qualitative fecal fat excretion in man.
Annals of nutrition & metabolism 1994;38(4):185-91.
1993: Buter J; Sleijfer D T; van der Graaf W T; de Vries E G; Willemse P H; Mulder N H
A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2.
Seminars in oncology 1993;20(6 Suppl 9):16-21.
1993: Biesma B; Pokorny R; Kovarik J M; Duffy F A; Willemse P H; Mulder N H; de Vries E G
Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer.
Cancer research 1993;53(24):5915-9.
1993: Timmer-Bosscha H; Timmer A; Meijer C; de Vries E G; de Jong B; Oosterhuis J W; Mulder N H
cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells.
Cancer research 1993;53(23):5707-13.
1993: Kroesen B J; ter Haar A; Spakman H; Willemse P; Sleijfer D T; de Vries E G; Mulder N H; Berendsen H H; Limburg P C; The T H
Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells.
Cancer immunology, immunotherapy : CII 1993;37(6):400-7.
1993: Kema I P; Schellings A M; Hoppenbrouwers C J; Rutgers H M; de Vries E G; Muskiet F A
High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients.
Clinica chimica acta; international journal of clinical chemistry 1993;221(1-2):143-58.
1993: Cats A; Mulder N H; de Vries E G; Oremus E T; Kreumer W M; Kleibeuker J H
Calcium phosphate: an alternative calcium compound for dietary prevention of colon cancer? A study on intestinal and faecal parameters in healthy volunteers.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1993;2(5):409-15.
1993: Guchelaar H J; Timmer-Bosscha H; Dam-Meiring A; Uges D R; Oosterhuis J W; de Vries E G; Mulder N H
Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell line.
International journal of cancer. Journal international du cancer 1993;55(3):442-7.
1993: de Vries E G; Gietema J A; Workman P; Scott J E; Crawshaw A; Dobbs H J; Dennis I; Mulder N H; Sleijfer D T; Willemse P H
A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer.
British journal of cancer 1993;68(3):641-4.
1993: Prins J; De Vries E G; Mulder N H
The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
Anticancer research 1993;13(5A):1373-85.
1993: Sinnige H A; Timmer-Bosscha H; Peters G F; De Vries E G; Mulder N H
Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
Anticancer research 1993;13(5A):1335-40.
1993: de Vries E G; van Gameren M M; Willemse P H
Recombinant human interleukin 3 in clinical oncology.
Stem cells (Dayton, Ohio) 1993;11(2):72-80.
1993: Kleibeuker J H; Welberg J W; Mulder N H; van der Meer R; Cats A; Limburg A J; Kreumer W M; Hardonk M J; de Vries E G
Epithelial cell proliferation in the sigmoid colon of patients with adenomatous polyps increases during oral calcium supplementation.
British journal of cancer 1993;67(3):500-3.
1993: de Jong S; Kooistra A J; de Vries E G; Mulder N H; Zijlstra J G
Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
Cancer research 1993;53(5):1064-71.
1993: Gietema J A; Guchelaar H J; de Vries E G; Aulenbacher P; Sleijfer D T; Mulder N H
A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion.
Anti-cancer drugs 1993;4(1):51-5.
1993: Gietema J A; de Vries E G; Sleijfer D T; Willemse P H; Guchelaar H J; Uges D R; Aulenbacher P; Voegeli R; Mulder N H
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.
British journal of cancer 1993;67(2):396-401.
1993: Lapré J A; De Vries H T; Termont D S; Kleibeuker J H; De Vries E G; Van der Meer R
Mechanism of the protective effect of supplemental dietary calcium on cytolytic activity of fecal water.
Cancer research 1993;53(2):248-53.
1993: de Jong S; Timmer-Bosscha H; de Vries E G; Mulder N H
Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line.
International journal of cancer. Journal international du cancer 1993;53(1):110-7.
1993: Mulder N H; Mulder P O; Sleijfer D T; Willemse P H; van der Ploeg E; Dolsma W V; de Vries E G
Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(5):668-71.
1993: Janssen R A; Buter J; Straatsma E; Heijn A A; Sleijfer D T; de Vries E G; Mulder N H; The T H; de Leij L
HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients.
Cancer immunology, immunotherapy : CII 1993;36(3):198-204.
1993: Prins J; de Vries E G; Mulder N H
Antisense of oligonucleotides and the inhibition of oncogene expression.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1993;5(4):245-52.
1993: Willemse P H; Gietema J A; Mulder N H; de Vries E G; Meijer S; Bouma J; Birkhofer M; Rastogi R B; Sleijfer D T
Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complex.
European journal of cancer (Oxford, England : 1990) 1993;29A(3):359-62.
1993: Sinnige H A; Buter J; de Vries E G; Uges D R; Roenhorst H W; Verschueren R C; Sleijfer D T; Willemse P H; Mulder N H
Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorin.
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1715-20.
1993: de Vries E G; Hamilton T C; Lind M; Dauplat J; Neijt J P; Ozols R F
Advanced ovarian cancer. Drug resistance, supportive care and dose intensity.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4 Suppl 4():57-62.
1993: De Vries E G; Kema I P; Slooff M J; Verschueren R C; Kleibeuker J H; Mulder N H; Sleijfer D T; Willemse P H
Recent developments in diagnosis and treatment of metastatic carcinoid tumours.
Scandinavian journal of gastroenterology. Supplement 1993;200():87-93.
1992: Meijer C; Mulder N H; Timmer-Bosscha H; Sluiter W J; Meersma G J; de Vries E G
Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
Cancer research 1992;52(24):6885-9.
1992: van der Zee A G; van Ommen B; Meijer C; Hollema H; van Bladeren P J; de Vries E G
Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
British journal of cancer 1992;66(5):930-6.
1992: Biesma B; Willemse P H; Mulder N H; Verschueren R C; Kema I P; de Bruijn H W; Postmus P E; Sleijfer D T; de Vries E G
Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
British journal of cancer 1992;66(5):850-5.
1992: Guchelaar H J; Uges D R; de Vries E G; Oosterhuis J W; Mulder N H
Combination therapy with cisplatin: modulation of activity and tumour sensitivity.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1992;4(6):388-93.
1992: Biesma B; Willemse P H; Mulder N H; Sleijfer D T; Gietema J A; Mull R; Limburg P C; Bouma J; Vellenga E; de Vries E G
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
Blood 1992;80(5):1141-8.
1992: Biesma B; Vellenga E; Willemse P H; de Vries E G
Effects of hematopoietic growth factors on chemotherapy-induced myelosuppression.
Critical reviews in oncology/hematology 1992;13(2):107-34.
1992: Timmer-Bosscha H; Mulder N H; de Vries E G
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
British journal of cancer 1992;66(2):227-38.
1992: van Veldhuisen D J; Hamer J P; Andriessen M P; de Vries E G; Lie K I
Additive value of transoesophageal echocardiography in the visualization of carcinoid heart disease.
The Netherlands journal of medicine 1992;41(1-2):17-21.
1992: Sleijfer D T; Janssen R A; Buter J; de Vries E G; Willemse P H; Mulder N H
Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1119-23.
1992: Postmus P E; Gietema J A; Damsma O; Biesma B; Limburg P C; Vellenga E; de Vries E G
Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1131-40.
1992: Guchelaar H J; Uges D R; Aulenbacher P; de Vries E G; Mulder N H
Stability of the new anticancer platinum analogue 1,2-diaminomethyl-cyclobutane-platinum(II)-lactate (lobaplatin; D19466) in intravenous solutions.
Pharmaceutical research 1992;9(6):808-11.
1992: Guchelaar H J; Hoekstra H J; de Vries E G; Uges D R; Oosterhuis J W; Schraffordt Koops H
Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
British journal of cancer 1992;65(6):898-902.
1992: Kema I P; de Vries E G; Schellings A M; Postmus P E; Muskiet F A
Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.
Clinical chemistry 1992;38(4):534-40.
1992: Smit E F; de Vries E G; Timmer-Bosscha H; de Leij L F; Oosterhuis J W; Scheper R J; Weening J J; Postmus P E; Mulder N H
In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.
International journal of cancer. Journal international du cancer 1992;51(1):72-8.
1992: Mulder N H; de Vries E G; Sleijfer D T; Schraffordt Koops H; Willemse P H
Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
British journal of cancer 1992;65(2):303-4.
1992: Willemse P H; Sleijfer D T; de Vries E G; Boonstra H; Bouma J; Mulder N H
A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):479-81.
1991: van der Zee A G; Hollema H; de Jong S; Boonstra H; Gouw A; Willemse P H; Zijlstra J G; de Vries E G
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.
Cancer research 1991;51(21):5915-20.
1991: Meijer C; Mulder N H; Timmer-Bosscha H; Peters W H; de Vries E G
Combined in vitro modulation of adriamycin resistance.
International journal of cancer. Journal international du cancer 1991;49(4):582-6.
1991: Smit A J; van Essen L H; de Vries E G
Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide.
Cancer 1991;67(11):2826-7.
1991: van der Graaf W T; de Vries E G; Uges D R; Nanninga A G; Meijer C; Vellenga E; Mulder P O; Mulder N H
In vitro and in vivo modulation of multi-drug resistance with amiodarone.
International journal of cancer. Journal international du cancer 1991;48(4):616-22.
1991: de Jong S; Mulder N H; de Vries E G; Robillard G T
NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell line.
British journal of cancer 1991;63(2):205-12.
1991: van der Zee A G; de Bruijn H W; Bouma J; Aalders J G; Oosterhuis J W; de Vries E G
Endodermal sinus tumor of the ovary during pregnancy: a case report.
American journal of obstetrics and gynecology 1991;164(2):504-6.
1991: de Vries E G; Biesma B; Willemse P H; Mulder N H; Stern A C; Aalders J G; Vellenga E
A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.
Cancer research 1991;51(1):116-22.
1991: Smit E F; Willemse P H; Sleijfer D T; Uges D R; Postmus P E; Meijer S; Terheggen P M; Mulder N H; de Vries E G
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(1):100-10.
1991: Vellenga E; Biesma B; Meyer C; Wagteveld L; Esselink M; de Vries E G
The effects of five hematopoietic growth factors on human small cell lung carcinoma cell lines: interleukin 3 enhances the proliferation in one of the eleven cell lines.
Cancer research 1991;51(1):73-6.
1991: Willemse P H; Aalders J G; de Bruyn H W; Mulder N H; Sleijfer D T; de Vries E G
CA-125 in ovarian cancer: relation between half-life, doubling time and survival.
European journal of cancer (Oxford, England : 1990) 1991;27(8):993-5.
1991: Nanninga A G; de Vries E G; Willemse P H; Oosterhuis B E; Sleijfer D T; Hoekstra H J; Mulder N H
Continuous infusion of chemotherapy on an outpatient basis via a totally implanted venous access port.
European journal of cancer (Oxford, England : 1990) 1991;27(2):147-9.
1991: Welberg J W; Kleibeuker J H; Van der Meer R; Mulder N H; De Vries E G
Calcium and the prevention of colon cancer.
Scandinavian journal of gastroenterology. Supplement 1991;188():52-9.
1991: Gietema J A; Willemse P H; Mulder N H; Oldhoff J; de Vries E G; Sleijfer D T
Alternating cycles of PVB and BEP in the treatment of patients with advanced seminoma.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1376-9.
1991: de Jong S; Zijlstra J G; Mulder N H; de Vries E G
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.
Cancer chemotherapy and pharmacology 1991;28(6):461-4.
1990: Mulder N H; Willemse P H; Schraffordt Koops H; de Vries E G; Sleijfer D T
Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
British journal of cancer 1990;62(6):1006-7.
1990: van der Graaf W T; de Vries E G
Mitoxantrone: bluebeard for malignancies.
Anti-cancer drugs 1990;1(2):109-25.
1990: Van der Meer R; Welberg J W; Kuipers F; Kleibeuker J H; Mulder N H; Termont D S; Vonk R J; De Vries H T; De Vries E G
Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile acids.
Gastroenterology 1990;99(6):1653-9.
1990: Meijer C; Mulder N H; de Vries E G
The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin.
Cancer treatment reviews 1990;17(4):389-407.
1990: Meijer C; Mulder N H; Hospers G A; Uges D R; de Vries E G
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
British journal of cancer 1990;62(1):72-7.
1990: Hospers G A; Meijer C; de Leij L; Uges D R; Mulder N H; de Vries E G
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
International journal of cancer. Journal international du cancer 1990;46(1):138-44.
1990: Welberg J W; de Vries E G; Hardonk M J; Mulder N H; Harms G; Grond J; Zwart N; Koudstaal J; de Ley L; Kleibeuker J H
Proliferation rate of colonic mucosa in normal subjects and patients with colonic neoplasms: a refined immunohistochemical method.
Journal of clinical pathology 1990;43(6):453-6.
1990: Mulder P O; de Vries E G; Uges D R; Scaf A H; Sleijfer D T; Mulder N H
Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.
British journal of cancer 1990;61(3):460-4.
1990: Willemse P H; de Vries E G; Mulder N H; Aalders J G; Bouma J; Sleijfer D T
Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1990;26(3):353-8.
1990: Willemse P H; van Lith J; Mulder N H; Aalders J G; Bouma J; de Vries E G; Sleijfer D T
Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis.
European journal of cancer (Oxford, England : 1990) 1990;26(3):345-52.
1990: de Vries E G; Greidanus J; Oosterhuis B E; de Langen Z J; Willemse P H
[Cytostatic treatment of patients at home]
Nederlands tijdschrift voor geneeskunde 1990;134(8):377-9.
1990: Hospers G A; de Vries E G; Mulder N H
The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
British journal of cancer 1990;61(1):79-82.
1990: de Jong S; Zijlstra J G; de Vries E G; Mulder N H
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
Cancer research 1990;50(2):304-9.
1990: van der Kolk B M; Mulder N H; Mantingh A; van den Berg E; Schraffordt Koops H; de Vries E G; Willemse P H; Sleijfer D T
Children born after their fathers had been treated with chemotherapy for testicular cancer.
European journal of obstetrics, gynecology, and reproductive biology 1990;34(1-2):167-70.
1990: Mulder N H; Sleijfer D T; de Vries E G; Schraffordt Koops H; Willemse P H
Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma.
Journal of cancer research and clinical oncology 1990;116(3):301-2.
1990: Zijlstra J G; de Jong S; de Vries E G; Mulder N H
Topoisomerases, new targets in cancer chemotherapy.
Medical oncology and tumor pharmacotherapy 1990;7(1):11-8.
1990: Biesma B; de Vries E G; Willemse P H; Sluiter W J; Postmus P E; Limburg P C; Stern A C; Vellenga E
Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever.
European journal of cancer (Oxford, England : 1990) 1990;26(9):932-6.
1990: Sinnige H A; Sleijfer D T; de Vries E G; Willemse P H; Mulder N H
Modification of 5-fluorouracil activity by high-dose methotrexate or leucovorin in advanced colorectal carcinoma.
European journal of cancer (Oxford, England : 1990) 1990;26(5):625-8.
1990: de Vries E G; Zijlstra J G
Morpholinyl anthracyclines: option for reversal of anthracycline resistance.
European journal of cancer (Oxford, England : 1990) 1990;26(6):659-60.
1990: Willemse P H; vd Burg M E; vd Gaast A; Neijt J P; ten Bokkel Huinink W W; Aalders J G; de Vries E G
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.
Cancer chemotherapy and pharmacology 1990;26 Suppl():S51-4.
1990: Marrink J; Sleijfer D T; de Vries E G; Schraffordt Koops H
Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage.
European journal of cancer (Oxford, England : 1990) 1990;26(9):969-72.
1989: Mulder P O; Bouman J G; Gietema J A; Van Rijsbergen H; Mulder N H; Van der Geest S; De Vries E G
Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral versus partial parenteral plus enteral nutrition.
Cancer 1989;64(10):2045-52.
1989: De Vries E G; Nanninga A G; Greidanus J; Oremus E T; Verschueren R C; Mulder N H; Sleijfer D T; Willemse P H
A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancer.
European journal of cancer & clinical oncology 1989;25(10):1509-10.
1989: de Vries E G; Meijer C; Timmer-Bosscha H; Berendsen H H; de Leij L; Scheper R J; Mulder N H
Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up.
Cancer research 1989;49(15):4175-8.
1989: Timmer-Bosscha H; Hospers G A; Meijer C; Mulder N H; Muskiet F A; Martini I A; Uges D R; de Vries E G
Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.
Journal of the National Cancer Institute 1989;81(14):1069-75.
1989: Greidanus J; de Vries E G; Mulder N H; Sleijfer D T; Uges D R; Oosterhuis B; Willemse P H
A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(6):790-7.
1989: Mulder P O; Willemse P H; Aalders J G; de Vries E G; Sleijfer D T; Sibinga C T; Mulder N H
High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer.
European journal of cancer & clinical oncology 1989;25(4):645-9.
1989: Mulder P O; Schröder P; de Vries-Hospers H G; van der Geest S; Sleijfer D T; Mulder N H; de Vries E G
Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumours.
The Netherlands journal of medicine 1989;34(3-4):126-31.
1989: de Vries E G; Smit E F; Vendrig D E; Holthuis J J; Mulder N H
Phase I study of 21 days continuous infusion with vindesine.
British journal of cancer 1989;59(3):471-2.
1989: Smit E F; Berendsen H H; de Vries E G; Mulder N H; Postmus P E
A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer.
Cancer chemotherapy and pharmacology 1989;25(3):202-4.
1989: Mulder N H; Sleijfer D T; de Vries E G; Schraffordt Koops H; Samson M J; Willemse P H
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.
Journal of cancer research and clinical oncology 1989;115(1):93-5.
1988: Greidanus J; Willemse P H; Uges D R; Oremus E T; De Langen Z J; De Vries E G
Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review.
Pharmaceutisch weekblad. Scientific edition 1988;10(6):237-45.
1988: Berendsen H H; de Leij L; de Vries E G; Mesander G; Mulder N H; de Jong B; Buys C H; Postmus P E; Poppema S; Sluiter H J
Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up.
Cancer research 1988;48(23):6891-9.
1988: Hospers G A; Mulder N H; de Jong B; de Ley L; Uges D R; Fichtinger-Schepman A M; Scheper R J; de Vries E G
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
Cancer research 1988;48(23):6803-7.
1988: Greidanus J; Willemse P H; Sleijfer D T; Mulder N H; Verschueren R C; Nieweg R; de Vries E G
Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.
European journal of cancer & clinical oncology 1988;24(4):801-2.
1988: Mulder P O; de Vries E G; Koops H S; Splinter T; Maas A; van der Geest S; Mulder N H; Sleijfer D T
Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.
European journal of cancer & clinical oncology 1988;24(4):675-9.
1988: Willemse P H; Dikkeschei L D; Mulder N H; van der Ploeg E; Sleijfer D T; de Vries E G
Clinical and endocrine effects of cyproterone acetate in postmenopausal patients with advanced breast cancer.
European journal of cancer & clinical oncology 1988;24(3):417-21.
1988: Gietema J A; de Vries E G; Meijer S; Offerman J J; Mulder P O; Sleijfer D T
Absence of relation between nutritional parameters and renal function in non-seminomatous testicular cancer patients.
Journal of cancer research and clinical oncology 1988;114(6):618-22.
1988: Hospers G A; Mulder N H; De Vries E G
Mechanisms of cellular resistance to cisplatin.
Medical oncology and tumor pharmacotherapy 1988;5(3):145-51.
1988: Sleijfer D T; Mulder P O; de Vries E G; Koops H S; Willemse P H; Sibinga C T; Mulder N H
High dose chemotherapy followed by autologous bone marrow re-infusion in relapsing or refractory testicular cancer.
Progress in clinical and biological research 1988;269():429-37.
1987: Zijlstra J G; de Vries E G; Muskiet F A; Martini I A; Timmer-Bosscha H; Mulder N H
Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell lines.
International journal of cancer. Journal international du cancer 1987;40(6):850-6.
1987: Greidanus J; de Vries E G; Nieweg M B; de Langen Z J; Willemse P H
Evaluation of a totally implanted venous access port and portable pump in a continuous chemotherapy infusion schedule on an outpatient basis.
European journal of cancer & clinical oncology 1987;23(11):1653-7.
1987: Willemse P H; Aalders J G; Bouma J; Mulder N H; Verschueren R C; de Vries E G; Sleijfer D T
Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: an update.
Gynecologic oncology 1987;28(3):268-77.
1987: de Vries E G; Greidanus J; Mulder N H; Nieweg M B; Postmus P E; Schipper D L; Sleijfer D T; Uges D R; Willemse P H
A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(9):1445-51.
1987: Meijer C; Mulder N H; Timmer-Bosscha H; Zijlstra J G; de Vries E G
Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line.
Cancer research 1987;47(17):4613-7.
1987: Nieweg R; Greidanus J; de Vries E G
A patient education program for a continuous infusion regimen on an outpatient basis.
Cancer nursing 1987;10(4):177-82.
1986: Zijlstra J G; de Jong S; van de Grampel J C; de Vries E G; Mulder N H
Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line.
Cancer research 1986;46(6):2726-9.
1986: de Jong S; Zijlstra J G; Timmer-Bosscha H; Mulder N H; de Vries E G
Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay.
International journal of cancer. Journal international du cancer 1986;37(4):557-61.
1986: Mulder N H; Mulder P O; Van der Geest S; Halie M R; Maas A; Orie J L; Postmus P E; Sleijfer D T; Smit Sibinga C T; De Vries E G
High-dosage chemotherapy with autologous bone marrow reinfusion in the treatment of patients with solid tumours. The Groningen experience, 1981-1986.
The Netherlands journal of medicine 1986;29(11):359-64.
1985: Postmus P E; Mulder N H; de Vries-Hospers H G; Mulder P O; Maas A; Meinesz A F; Sleijfer D T; de Vries E G
High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study.
European journal of cancer & clinical oncology 1985;21(12):1467-70.
1984: Postmus P E; Mulder N H; Sleijfer D T; Meinesz A F; Vriesendorp R; de Vries E G
High-dose etoposide for refractory malignancies: a phase I study.
Cancer treatment reports 1984;68(12):1471-4.
1984: Postmus P E; de Vries E G; De Vries-Hospers H G; Vriesendorp R; van Imhoff G W; Holthuis J J; Sibinga C T; Sleijfer D T; Mulder N H
Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study.
European journal of cancer & clinical oncology 1984;20(6):777-82.
1984: Mulder N H; Meinesz A F; Sleijfer D T; Postmus P E; De Vries E G; Van der Geest S; Orie J L; Vriesendorp R
Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT).
The Netherlands journal of medicine 1984;27(10):389-92.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Elisabeth de Vries

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Elisabeth de Vries (preview)

All Publications